RCM
ISEE

RA Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

RA Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-310,554
Closed -$13.9M – 59
2014
Q4 		$13.9M Sell
310,554
-278,387
-47% -$11.7M 1.5% 21
2014
Q3 		$22.9M Buy
588,941
+61,000
+12% +$2.39M 2.71% 11
2014
Q2 		$22.3M Sell
527,941
-1,209,915
-70% -$44.4M 2.26% 14
2014
Q1 		$62M Buy
1,737,856
+137,401
+9% +$4.63M 4.45% 9
2013
Q4 		$51.8M Buy
+1,600,455
New +$47.5M 6.03% 6

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RA Capital Management's ISEE Position: Q1 2015 in Review

RA Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2015, closing a stake of 310,554 shares — an estimated $13.9M sold.

RA Capital Management first reported a position in ISEE in Q4 2013 and held it in 5 quarters. The position peaked at $62M in Q1 2014. 129 funds tracked by Wall St. Rank hold ISEE as of Q1 2015.

  • RA Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • RA Capital Management sold 310,554 IVERIC bio, Inc. Common Stock shares in Q1 2015, an estimated $13.9M.
  • RA Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • RA Capital Management's IVERIC bio, Inc. Common Stock position peaked at $62M in Q1 2014.
  • 129 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2015.

Based on RA Capital Management's 13F filing for Q1 2015, filed 15 May 2015.